Bausch Health Companies Inc (NYSE:BHC)
$ 7.53 0.05 (0.67%) Market Cap: 2.78 Bil Enterprise Value: 24.44 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 78/100

Bausch Health Companies Inc at Goldman Sachs Leveraged Finance Conference Transcript

May 07, 2019 / 05:40PM GMT
Release Date Price: $25.49 (+0.04%)
Franklin Jarman
Goldman Sachs Group Inc., Research Division - VP and Senior Analyst

So thanks, everyone, for joining us. I'm Frank Jarman, the high-yield health care analyst here at Goldman Sachs. Very excited to have Paul Herendeen here, who's the Executive Vice President and Chief Financial Officer of Bausch Health. So thanks very much for joining us, Paul.

Paul S. Herendeen
Bausch Health Companies Inc. - Executive VP & CFO

Glad to be here, Frank.

Questions & Answers

Franklin Jarman
Goldman Sachs Group Inc., Research Division - VP and Senior Analyst

Great. So maybe just to kick things off and to level set for folks, you guys have been very successful at stabilizing the business over the last few years, and as we think about this past quarter, I think it was also pretty important, it was very strong organic growth quarter. I think the strongest since 2015. And so as you guys think about the next phase of value creation, how are you weighing some of the limitations with regards to your balance sheet

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot